Alexander Mueller is a postdoctoral researcher and recent PhD graduate at the Institute for Molecular Bioscience at the University of Queenslans in Brisbane, Australia. His PhD in the field of sensory neuropharmacology focused on the discovery, characterization and pre-clinical development of safer and more effective painkillers using analgesic ion channel inhibitors from venom peptides. He utilized pharmacological, biochemical, fluorescent imaging, electrophysiological, behavioral, and high-throughput screening techniques as well as peptide chemistry and recombinant protein and peptide expression. Prior to his PhD studies, Alexander obtained his graduation as a Technical Laboratory Assistant in Molecular Biology and Bioinformatics from a technical college in Germany, followed by an undergraduate degree in Pharmacy from the University of Tuebingen, Germany. Thereafter, he gained experiences as Research Assistant in cell-based assays and pharmacology at the Institute for Molecular Bioscience, The University of Queensland, Australia as well as in experimental pain research and surgical techniques at the University Hospital Erlangen, Germany, where he worked on ion channels and other membrane proteins involved in cold transduction and orofacial pain befor his return to Australia for his PhD. Alexander is currently working on elucidating the pharmacology of an understudied group of venom peptides.